sur Bausch Health Companies Inc. (NASDAQ:BHC)
Bausch Health Expands Board with New Appointments
Bausch Health Companies Inc., a global pharmaceutical company, announced the appointment of Michael Goettler and Sandra Leung to its Board of Directors, effective July 22, 2025. This expands the Board from ten to twelve members.
Michael Goettler, previously CEO of Viatris, has a strong track record in leading pharmaceutical companies. He is recognized for driving transformation and enhancing healthcare solutions and will serve on the Talent and Compensation and Science and Technology Committees.
Sandra Leung, formerly with Bristol Myers Squibb, brings extensive experience in strategic legal counsel. She will join the Nominating and Corporate Governance Committee. John A. Paulson, Board Chairperson, expressed confidence in their contributions to Bausch Health's evolution and strategy.
R. H.
Copyright © 2025 FinanzWire, tous droits de reproduction et de représentation réservés.
Clause de non responsabilité : bien que puisées aux meilleures sources, les informations et analyses diffusées par FinanzWire sont fournies à titre indicatif et ne constituent en aucune manière une incitation à prendre position sur les marchés financiers.
Cliquez ici pour consulter le communiqué de presse ayant servi de base à la rédaction de cette brève
Voir toutes les actualités de Bausch Health Companies Inc.